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Background—The composition of atherosclerotic plaque affects the likelihood of an
atherothrombotic event but prospective studies relating risk factors to carotid wall and plaque
characteristics measured by MRI are lacking. We hypothesized that traditional risk factors are
predictors of carotid wall and plaque characteristics measured two decades later.
Methods and Results—A high-resolution contrast-enhanced MRI exam of the carotid artery was
performed in 1769 participants. Measures of carotid wall volume and maximum thickness; lipid core
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presence, volume and maximum area; and fibrous cap thickness were performed centrally. The
average age of the sample was 70 years, 57% female, 81% white, and 19% African American. Greater
age, total and LDL cholesterol, male gender, white race, diabetes, hypertension and smoking as
measured at baseline, were all significant predictors of increased wall volume and maximum wall
thickness 18 years later. An analysis of lipid core was restricted to the 1180 participants with
maximum wall thickness ≥1.5mm. Lipid core was observed in 569 individuals (weighted percentage
= 42%). Baseline age, total and LDL cholesterol were predictors of presence of lipid core 18 years
later; however, these relationships were attenuated after adjustment for wall thickness. Concurrently
measured LDL was associated with greater lipid core volume, independent of wall thickness.
Concurrently measured glucose and body mass index were inversely associated fibrous cap thickness.
Conclusions—Traditional atherosclerosis risk factors are related to increased wall volume and
wall thickness two decades later, but they do not discriminate characteristics of plaque composition
(core and cap) independent of wall size.
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The composition of atherosclerotic plaque affects the likelihood of an atherothrombotic
event but prospective studies relating risk factors to carotid wall and plaque characteristics
measured by MRI are lacking. We hypothesized that traditional risk factors are predictors
of carotid wall and plaque characteristics measured two decades later. We measured carotid
wall volume and maximum thickness; lipid core presence, volume and maximum area; and
fibrous cap thickness in an epidemiologic cohort of 1769 men and women, average age 70
years, using high-resolution contrast-enhanced MRI. Greater age, total and LDL
cholesterol, male gender, white race, diabetes, hypertension and smoking as measured at
baseline, were all predictors of increased wall volume and maximum wall thickness 18 years
later. Age, total and LDL cholesterol were predictors of presence of lipid core 18 years later,
primarily through their association of increased wall thickness. LDL was associated with
greater lipid core volume. Increased fasting glucose and obesity were associated with a thin
fibrous cap. These results confirm the importance of traditional risk factors in predicting
atherosclerosis. Specifically, risk factors measured in mid-life predict atherosclerosis in late
life. These findings have implications for risk factor modification in mid-life and future risk
of cardiovascular disease.
The composition of atherosclerotic plaque plays a critical role in occurrence of clinical
cardiovascular and cerebrovascular events (1,2). The plaque is composed of distinct
morphologic features including a fibrous cap comprised of smooth muscle cells and fibrotic
tissue, and a lipid core containing fat-laden macrophages and extracellular lipids. Histologic
studies have led to the recognition that plaque structure influences the risk of plaque rupture.
Specifically, a plaque with a thin fibrous cap and a large lipid core is more prone to rupture
(3). Because a major cause of ischemic cerebrovascular events is carotid plaque rupture, as
observed in both histologic (4) and magnetic resonance imaging (MRI)-based studies (5), it is
important to identify the factors that alter plaque structure, and those factors that lead to plaque
rupture. MRI has enabled the noninvasive characterization of atherosclerotic plaque in
population-based samples (6).
Few studies have characterized correlates of plaque structure of the carotid artery; most have
examined correlates of the coronary arteries, and then usually as cross-sectional assessments
in clinical or autopsied populations (7–9). Only one report has examined plaque characteristics
and their determinants in a population-based or epidemiologic sample (10). The present report
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describes results from the Atherosclerosis Risk in Communities (ARIC) Study in which
contrast enhanced MRI studies of the carotid artery were obtained approximately two decades
after a baseline examination. Our study aim was to evaluate the ability of traditional risk factors
for atherosclerosis, measured two decades previously and concurrent with the MRI exam, to
predict MRI-detectable carotid wall and plaque characteristics.
Methods
The study sample consisted of 2066 members of the ARIC study cohort who participated in
the Carotid MRI substudy in 2004–2005. ARIC is a cohort study of atherosclerosis among
15,792 African American and white adults initially examined between 1987 and 1989 (11,
12). For the substudy, a stratified sampling plan was used in order to increase the prevalence
of informative plaques while maintaining the ability to make population-based inferences. The
goal was to recruit 1200 participants with high values of maximum carotid artery intimal medial
thickness (IMT) at their last or penultimate ultrasound examination, and 800 individuals
randomly sampled from the remainder of the IMT distribution. Field-center-specific cutpoints
of carotid IMT were adjusted over the recruitment period to approximately achieve this goal,
with 100% sampling above the cutpoint, and a sampling fraction below the cutpoint to achieve
the desired 800. By the end of the recruitment period, cutpoints ranged from 1.00 to 1.28 mm
representing the 68th to the 73rd percentiles of maximum IMT. These cutpoints allowed for
recruitment of similar numbers of participants with high IMT from each field center.
Recruitment lists were created by the coordinating center by sampling from above and below
the IMT cutpoint as indicated by the sampling plan. Lists included an indicator for which
carotid had the greatest IMT. Ineligibility criteria for the substudy included standard
contraindications to the MRI exam or contrast agent, carotid revascularization on either side
for the low IMT group or on the side selected for imaging for the high IMT group, and
difficulties in completing informed consent. A total of 4306 persons were contacted and invited
to participate in the substudy; 1403 refused, 346 were ineligible, 491 reported medical
conditions which precluded their participation, and 2066 (48%) participated (Figure 1). Those
who refused were more likely to be African American, and have diabetes, hypertension, and
obesity, compared to those who participated.
Measurement protocols were identical at the baseline ARIC examination and the Carotid MRI
substudy examination conducted approximately 18 years later. Smoking and prescription drug
use were ascertained by interview. Fasting blood samples were assayed for total and HDL
cholesterol, and glucose using conventional techniques. LDL cholesterol was calculated
according to the Friedewald formula. High sensitivity c-reactive protein (CRP) and urinary
albumin and creatinine were obtained only at the substudy time point. Albumin-creatinine ratio
(ACR) was calculated as a measure of albuminuria. Resting blood pressure was determined
using a random-zero sphygmomanometer. Hypertension was defined as systolic or diastolic
blood pressure of 140 or 90 mmHg or greater, or use of antihypertensive medication. Diabetes
was defined as a fasting glucose ≥7.0 mmol/L, a nonfasting glucose level ≥11.1 mmol/L, or a
self-report of physician-diagnosed diabetes or treatment. Previous history of CVD included
adjudicated myocardial infarction, stroke, and/or revascularization procedure (13). The study
was approved by the institutional review committees and participants provided informed
consent.
MRI Scanning
A contrast enhanced MRI exam was performed according to a standard protocol. Each study
was acquired on a 1.5T whole body scanner equipped with a 4-element phased array carotid
coil. A 3-dimensional time-of-flight MR angiogram (MRA) was acquired through both carotid
bifurcations. Detailed black blood MRI (BBMRI) images were acquired through the
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extracranial carotid bifurcation known to have a thicker maximum wall, unless the contralateral
carotid bifurcation wall appeared thicker on the MRA to the technologist, in which case the
contralateral vessel was chosen for detailed imaging. BBMRI imaging was achieved using an
ECG-gated, 2-dimensional double inversion recovery fast spin echo sequence with the
inversion time set to suppress the signal of blood. The detailed images included 16 transverse
T1-weighted, fat-suppressed BBMRI slices (repetition time/echo time, 1RR/5msec; thickness,
2mm; acquired in-plane resolution, 0.51×0.58mm2; total longitudinal coverage, 3.2cm)
oriented perpendicular to the vessel and centered through the thickest segment of the artery or
plaque, if present. These 16 slices were acquired five minutes after the intravenous injection
of gadodiamide.
Of the 2066 individuals who participated in the Carotid MRI substudy, 1938 completed an
MRI examination (Figure 1). Reasons for incomplete MRI examinations (N=128, 6%)
included: ineligible at the time of the scan (n=5, 4%); inability to lie in the scanner (n=7, 5%);
aborted scan (n=14, 11%); refusal (e.g., claustrophobia; n=38, 30%); and not recorded (n=64,
50%).
MRI Reading
Seven readers were trained to interpret the MRI images and contour the wall components on
the postcontrast BBMRI images using specialized software. Readers drew contours to delineate
the lumen, outer wall, lipid core, and calcification (Figure 2). Calcification was identified as
areas of signal loss on the corresponding TOF MRA images. Lipid core was delineated based
on the preferential enhancement of the surrounding fibrous tissue (14,15), and had intermediate
signal on TOF images. The fibrous cap contour was automatically generated to approximate
the lumen and lipid core contours. Only eight of 16 slices were analyzed (1.6cm segment),
selected as those centered on the slice with the thickest wall. All exams were assigned quality
scores (0, 1, or 2) based on image quality and protocol adherence. Exams receiving a quality
score of zero were not analyzed.
Vessel walls were divided into 12 radial segments and mean thickness values were generated
for each segment. Mean thickness values were also generated for the entire fibrous cap. Area
measurements were calculated for the lipid core and calcification contours. Volumetric data
were computed by integrating area measurements over all eight slices examined. Details
regarding the MRI methods are contained in a supplement.
Attributes could not be ascertained in 1938 scans for the common carotid artery (CCA, n=18,
11%), internal carotid artery (ICA, n=87, 51%), or both (n=64, or 38%), because of protocol
deviations or poor image quality (n=143, 7%).
Reliability Study
Reliability coefficients were obtained from an internal reliability study in which 130 scans
were re-read by the same or a different reader, and 52 participants were re-scanned within two
months. Reliability of lipid core and cap measurements was based on persons with lipid core:
40 repeat readings and 14 repeat scans. The inter- and intra-technician reliability was estimated
using the intra-class correlation coefficient (16) and can be interpreted as: greater than 0.75,
excellent; 0.4 to 0.75, fair to good; and less than 0.4, poor (17). Reliability based on repeated
readings was excellent for wall volume, wall thickness, and lipid core volume (0.76 to 0.85),
and fair to good for cap thickness measures (0.60) and lipid core area (0.72). Reliability based
on repeated scans was also excellent for wall thickness and volume (0.77 and 0.79), fair to
good for minimum cap thickness and lipid core area (0.49 and 0.66), and poor for lipid core
volume and cap thickness (0.30 and 0.38). Kappa coefficients for repeated readings and
repeated scans for lipid core presence were 0.61 and 0.45.
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All analyses were based on methods appropriate for stratified random sampling. Analyses were
weighted by the inverse of the sampling fractions in the eight sampling strata (2 IMT strata
X 4 field centers). Analyses were conducted using SAS version 9.1 or SUDAAN. The analysis
approach considered both baseline and concurrent (Year 18) measures of risk factors in relation
to MRI measures in those 1769 participant exams in which a complete set of MRI parameters
are available (Figure 1). Wall thickness and wall volume were analyzed in the full set. Due to
the resolution constraints of the scan, we restricted consideration of lipid core to those 1180
participants whose maximum wall thickness was ≥1.5 mm (weighted percentage = 62%) Only
four lipid cores were excluded using this cutpoint. Measures of lipid core volume and area,
and fibrous cap thickness were analyzed as continuous variables among those 569 participants
with a lipid core (weighted percentage = 42%). An additional analysis considered lipid core
presence as a dichotomous variable. Standardized regression coefficients are presented for
linear and logistic regression models, standardizing by one standard deviation of exposure and
outcome (for continuous outcomes) with adjustment for age, race, and gender. Lipid core
volume and areas were also adjusted for maximum wall thickness.
Results
The average age of the sample was 70 years, 57% female, and 19% African American. The
average follow-up time between the baseline ARIC examination and the substudy was 18 years
(range: 15 – 20 years). LDL and total cholesterol declined between baseline and year 18,
consistent with an increase in the use of cholesterol lowering medications (Table 1). BMI
increased over this period by approximately 1 to 2 kg/m2 in each gender-race group.
Approximately 20% of white participants and 35% of African American participants had
diabetes by year 18. Smoking declined by approximately half over this period.
ICA wall volume and maximum segmental wall thickness were markedly higher in men than
women and in whites than African Americans (Table 2). Lipid cores were evaluated in carotid
arteries in which the maximum wall thickness was equal to or exceeded 1.5mm. This
corresponded to 62% of all arteries, with 42% containing lipid core. The volume and area of
the lipid core was greatest in white men, corresponding to their larger wall volume. Calcium
areas were also greater in white men. The mean fibrous cap thickness similarly was greatest
in white men, with no difference observed across the groups for minimum cap thickness.
Greater baseline age, male gender, white race, total cholesterol, LDL cholesterol, glucose,
BMI, and presence of diabetes, hypertension, and smoking were all associated with increased
total wall volume (Table 3). The same risk factors except BMI were associated with maximum
segmental wall thickness. Some of these associations, when measured concurrently, persisted,
particularly for wall volume. In other cases, concurrently measured risk factors were not
associated with outcome even though the baseline risk factor was, e.g., glucose, BMI.
Increased baseline levels of total cholesterol and LDL cholesterol, as well as age, were the only
factors which predicted presence of lipid core 18 years later (Table 4). A one standard deviation
increase in total cholesterol (approximately 1.0 mmol/L) increased the odds of lipid core
presence by 26% (β=0.23, odds ratio=1.26, p=0.003). These relationships were attenuated with
adjustment for wall thickness, which was itself strongly associated with presence of lipid core.
The wall thickness adjusted odds of lipid core for a one standard deviation increase in total
cholesterol was 1.16 (p=0.10). No risk factor measured at year 18 was associated with presence
of lipid core.
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Two risk factors were significantly, albeit modestly associated with the size of the lipid core
(Table 5). Younger age at baseline (p=0.03) and increased LDL at year 18 (p=0.02) were
associated with greater lipid core volume at year 18, independent of wall thickness.
Two risk factors were associated with cap thickness measures (Supplemental Results Table).
Glucose measured at Year 18 was inversely associated with cap thickness (β= −0.13, p=0.01)
and BMI measured at Year 18 was inversely associated with minimum cap thickness (β=
−0.13, p=0.04).
Discussion
We have examined the correlates of atherosclerotic plaque size and composition in the ICA in
a population-based cohort. Our principal findings are that greater baseline levels of total
cholesterol, LDL cholesterol, glucose, and presence of diabetes, hypertension, and smoking,
are all significant predictors of increased total wall volume and maximum wall thickness 18
years later. In contrast, the only baseline risk factors that predicted the presence of a lipid core
were age, total cholesterol and LDL cholesterol. Perhaps not surprisingly, these relationships
were mediated through greater wall thickness resulting from the intra-wall accumulation of
lipids. Few risk factors were associated with the size of the lipid core and the thickness of the
fibrous cap; the associations were sporadic and modest in size. Of note, two metabolic factors,
increased glucose levels and obesity, were associated with a thinner fibrous cap. These findings
emphasize the importance of traditional risk factors in predicting carotid wall size, but not
necessarily the composition of the carotid plaque.
We evaluated risk factors that are known to be associated with carotid IMT in ARIC and other
studies (18–20) confirming the expected associations with total and LDL cholesterol, glucose,
diabetes, hypertension, and smoking. A slight difference in risk factor profiles was observed
between total wall volume and maximum wall thickness: in particular, baseline BMI predicted
total wall volume but not maximum wall thickness. This might be explained by wall volume
reflecting the vessel diameter, which depends on body size rather than CV risk factors. In
addition, diabetes was a stronger predictor of wall volume than wall thickness. The latter
finding may be supported by previous work in which diabetes was shown to increase total and
distal plaque burden in dissected coronary arteries (21). MRI-measured wall volume may be
a better measure of distal plaque burden than wall thickness.
Only one other previous study has examined the correlates of atherosclerotic plaque
characteristics in a population-based cohort. The Multi-Ethnic Study of Atherosclerosis study
has reported that total cholesterol was the sole cross-sectional correlate of lipid core presence
in 151 individuals with a lipid core but free of clinically apparent cardiovascular disease (10).
Compared to those in the lowest tertile of total cholesterol, and adjusted for wall thickness, the
odds of lipid core presence for participants in the middle and highest tertiles were 2.76 and
4.63. Our findings differ from these in two ways. In ARIC, neither baseline nor year 18 wall
thickness adjusted total cholesterol levels were significantly associated with presence of lipid
core. Furthermore, the cross-sectional association between total cholesterol and presence of
lipid core was inverse, albeit non-significant. (This inverse association was not explained by
lipid lowering medications as it persisted in the subset not taking these medications; not shown).
The difference in these study results may be explained by differences in the underlying cohorts
including a higher prevalence of cores observed in MESA than in ARIC and greater use of
lipid lowering medications in ARIC than in MESA.
To our knowledge, this is the first population-based study of risk factor associations of
quantitative measure of fibrous cap thickness. Most other studies have been conducted in small
clinical or autopsy samples, and have focused on a categorical (not quantitative) assessment
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of fibrous cap, i.e., whether the plaque is ruptured or intact (5,9). In our study, the inverse
associations of concurrently measured glucose and BMI with cap thickness are consistent with
the hypothesis that risk factors are associated with a thin fibrous cap. These particular
observations suggest a metabolic/inflammatory mechanism by which the composition of the
plaque is modified.
The contrast between the large numbers of risk factors associated with wall thickness/volume
versus the limited set of risk factors associated with plaque composition is striking. There are
several possible explanations for this discrepancy. First, repeatability coefficients for plaque
composition characteristics, especially for repeated scans, were modest. Thus, measurement
error is a possible explanation for the weaker findings for the lipid core and fibrous cap
thickness measures. However, we have only moderate confidence in the estimates of
repeatability for plaque composition characteristics; the coefficients were based upon only 14
repeated studies. In contrast, the reliability estimates were excellent for wall thickness/volume
measures. This is not unexpected. Repeatability depends upon the range of normal values.
Consequently, repeatability was best for the largest structures (wall thickness) and poorest of
the smallest structures (cap thickness). Despite weak reliability, the descriptive statistics that
we report here for plaque composition characteristics are consistent with measures obtained
from pathology studies (5,22), giving us confidence in the validity of the measures. Our cap
thickness measurements (Table 2) are marginally higher than those reported for non-ruptured
sites in symptomatic plaque specimens (22). This difference was anticipated given that
symptomatic would likely have thinner caps. Furthermore, with a linear resolution close to
500µ, we expect some overestimation of our cap thickness measurements. In conclusion, for
the smaller structures in particular, measurements are accurate but not highly reproducible,
possibly explaining the weaker relationships for plaque composition measures.
There are other possible explanations for the generally null findings. The resolution of the MRI
images limits our ability to characterize small plaques, thus we were able to study only the
largest plaques found within the thickest arterial walls. By truncating the distribution of lipid
core volume and cap thickness, we have thereby restricted the range of values and possibly the
association with risk factors. Another possibility is that risk factor profiles differ for calcified
and non-calcified plaques. However, exclusion of heavily calcified plaques had no effect on
the strength of the associations between risk factors and lipid core (not shown). Finally, risk
factors for plaque composition may truly differ from risk factors for wall thickness and wall
volume. Other factors may play a role in the development and progression of atherosclerotic
plaque, particularly those in the inflammatory and coagulation pathways (23). For example,
we have recently reported that variation within the promoter region of the matrix
metalloproteinase-2 gene is associated with fibrous cap thickness (24).
A limitation is the characterization of a single plaque and the assumption that it represents the
character of plaques systemically. The one plaque we characterized was the largest in the
visualized carotid arteries. Consequently, we assume that the morphology of this plaque and
its risk factor relationships are representative of plaques throughout. Indeed, there is evidence
to support the contention that plaque characteristics are moderately correlated across major
arterials beds (3,25). Nonetheless, these studies are small and limited usually to homogeneous
samples (e.g., symptomatic patients). Since the wall thickness/volume measures and the plaque
composition measures were similarly assessed at one arterial location, this argument does not
explain why only a limited set of risk factor relationships was observed for plaque composition.
There are many strengths of the present study including its being a well-characterized sample
of a population-based cohort with data collected over an 18 year period. This has provided an
opportunity to characterize contemporaneous as well as previous risk factors in relation to
outcome measures. A standardized MRI protocol with central reading facility was utilized.
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Quality control data were collected allowing an assessment of the reliability of the MRI
measures. Furthermore, this is the first population-based study of plaque in which all
participants received a contrast-enhanced MRI examination, which improves reliability
considerably (14,26).
We have found that traditional CVD risk factors measured two decades previously can predict
carotid wall thickness and volume. In contrast, only total cholesterol and LDL cholesterol were
associated with the presence of a lipid core, a relationship that was mediated through greater
wall thickness. Very few relationships were observed between risk factors and quantity of lipid
core and thickness of fibrous cap. Notably, two metabolic factors, increased glucose levels and
obesity, were associated with a thinner fibrous cap. In conclusion, traditional risk factors
increase the extent of atherosclerosis, but in the presence of atherosclerosis they do not
discriminate plaque composition as measured by MRI.
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Schematic describing the ARIC Carotid MRI Substudy Sample and Resulting MRI Measures
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Contiguous transverse contrast-enhanced black blood MRI images through a left carotid artery
plaque in an ARIC participant with (a) and without (b) manually-drawn contours. Contours
delineate the lumen (red), outer wall (green), and lipid core (blue). Calcification was manually
shaded (orange). Automated software divided the wall into 12 radial segments and the cap into
radial segments at 15 degree increments (c). Segmental wall thickness values were determined
by averaging the yellow thickness measurements within each wall segment, and segmental cap
thickness values were determined by averaging the red thickness measurements within each
cap segment (c).
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Table 3
Relationship between continuous wall thickness measures and risk factors obtained at Baseline and Year 18,
adjusting for age, race, and gender (standardized beta coefficients*, p-value in parentheses).
Total wall volume
N=1769
Maximum segmental wall thickness
N=1769
Baseline Year 18 Baseline Year 18
Age 0.10 (<0.0001) 0.09 (0.001) 0.12 (<0.0001) 0.11 (<0.0001)
Race (ref=white) −0.21 (<0.0001) −0.22 (<0.0001) −0.23 (<0.0001) −0.23 (<0.0001)
Gender (ref=female) 0.60 (<0.0001) 0.60 (<0.0001) 0.37 (<0.0001) 0.38 (<0.0001)
Total cholesterol 0.07 (0.02) 0.08 (0.003) 0.12 (<0.0001) 0.04 (0.12)
HDL 0.04 (0.43) 0.003 (0.92) 0.006 (0.89) −0.008 (0.77)
LDL 0.06 (0.04) 0.06 (0.02) 0.12 (<0.0001) 0.04 (0.15)
Glucose 0.11 (0.01) 0.02 (0.49) 0.07 (0.01) 0.04 (0.14)
BMI 0.07 (0.02) 0.04 (0.14) 0.03 (0.29) −0.005 (0.86)
Diabetes 0.53 (0.01) 0.20 (0.004) 0.39 (0.03) 0.16 (0.02)
Hypertension 0.18 (0.009) 0.16 (0.005) 0.18 (0.007) 0.19 (0.001)
Smoking 0.18 (0.01) 0.17 (0.07) 0.27 (<0.0001) 0.26 (0.01)
CRP NA 0.04 (0.18) NA 0.04 (0.19)
ACR NA 0.09 (0.002) NA 0.07 (0.01)
*
Number of standard deviations differences in MRI variables associated with one standard deviation difference in continuous risk factors (from Table
1), or between categories of a dichotomous variable. Significant (p<0.05) results are indicated in bold italics.
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Table 4
Relationship between presence of lipid core and risk factors obtained at Baseline and Year 18, restricted to
participants with maximum wall thickness >= 1.5 mm, adjusting for age, race, and gender, and adjusting for age,
race, gender, and wall thickness (standardized beta coefficient s*, p-value in parentheses).
Presence of Lipid Core
N=1180
Unadjusted for wall thickness Adjusted for wall thickness
Baseline Year 18 Baseline Year 18
Age 0.20 (0.01) 0.21 (0.01) 0.15 (0.07) 0.16 (0.06)
Race (ref=white) 0.19 (0.31) 0.19 (0.32) 0.34 (0.10) 0.34 (0.10)
Gender (ref=female) 0.17 (0.25) 0.18 (0.25) −0.05 (0.78) −0.04 (0.79)
Wall thickness NA NA 1.14 (<0.0001) 1.14 (<0.0001)
Total cholesterol 0.23 (0.003) −0.10 (0.19) 0.15 (0.10) −0.09 (0.26)
HDL −0.02 (0.86) −0.13 (0.14) −0.01 (0.90) −0.12 (0.21)
LDL 0.19 (0.02) −0.07 (0.36) 0.12 (0.16) −0.07 (0.38)
Glucose 0.08 (0.26) 0.08 (0.30) 0.02 (0.83) 0.10 (0.24)
BMI −0.02 (0.79) −0.04 (0.62) −0.10 (0.27) −0.08 (0.37)
Diabetes −0.11(0.74) 0.08 (0.65) −0.44 (0.23) 0.06 (0.76)
Hypertension 0.28 (0.12) 0.16 (0.34) 0.06 (0.75) 0.06 (0.72)
Smoking 0.23 (0.22) 0.16 (0.56) 0.01 (0.98) −0.11 (0.68)
CRP NA 0.03 (0.71) NA 0.01 (0.90)
ACR NA 0.05 (0.48) NA 0.01 (0.93)
*
Beta coefficient for presence of lipid core associated with one standard deviation difference in continuous risk factors (from Table 1), or between
categories of a dichotomous variable. Significant (p<0.05) results are indicated in bold italics.
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Table 5
Relationship between continuous lipid core measures and risk factors obtained at Baseline and Year 18, restricted
to participants with maximum wall thickness >= 1.5 mm who have lipid core present, adjusting for age, race,
gender, and wall thickness (standardized beta coefficients*, p-value in parentheses).
Total lipid core volume
N=573
Maximum lipid core area
N=573
Baseline Year 18 Baseline Year 18
Age −0.06 (0.03) −0.04 (0.10) −0.03 (0.32) −0.02 (0.54)
Race (ref=white) −0.06 (0.36) −0.05 (0.41) −0.02 (0.76) −0.01 (0.81)
Gender (ref=female) 0.05 (0.38) 0.05 (0.37) 0.03 (0.53) 0.03 (0.52)
Wall thickness 0.80 (<0.0001) 0.80 (<0.0001) 0.85 (<0.0001) 0.85 (<0.0001)
Total cholesterol −0.001 (0.98) 0.04 (0.09) −0.004 (0.84) 0.04 (0.15)
HDL 0.06 (0.14) −0.003 (0.90) 0.04 (0.29) −0.01 (0.72)
LDL −0.03 (0.32) 0.06 (0.02) −0.02 (0.39) 0.04 (0.11)
Glucose 0.03 (0.46) 0.003 (0.90) 0.03 (0.17) 0.02 (0.38)
BMI −0.03 (0.37) −0.02 (0.64) −0.02 (0.59) 0.01 (0.87)
Diabetes 0.17 (0.38) −0.05 (0.45) 0.20 (0.14) −0.05 (0.40)
Hypertension −0.09 (0.18) 0.05 (0.44) −0.08 (0.19) 0.04 (0.50)
Smoking −0.02 (0.86) −0.12 (0.28) −0.05 (0.53) −0.19 (0.06)
CRP NA 0.02 (0.39) NA 0.02 (0.41)
ACR NA −0.02 (0.44) NA −0.03 (0.17)
*
Number of standard deviations differences in MRI variables associated with one standard deviation difference in continuous risk factors (from Table
1), or between categories of a dichotomous variable. Significant (p<0.05) results are indicated in bold italics.
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